2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Brain Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alhonen-Hongisto, L; Deen, DF; Marton, LJ | 1 |
Dinapoli, RP; Eagan, RT; Groover, RV; Hermann, RC; Layton, DD | 1 |
Bigner, DD; Bigner, SH; Rawlings, CE; Schold, SC | 1 |
Assietti, R; Butti, G; Gaetani, P; Knerich, R; Paoletti, P | 1 |
Eyre, HJ; McCracken, JD; Neilan, BA; O'Bryan, RM; Taylor, SA | 1 |
Berens, ME; Dougherty, DV; Giblin, JR; Hoifodt, HK; Rosenblum, ML; Tveit, K | 1 |
Da Silva, VF; Feeley, M; Goyal, R; Raaphorst, GP | 1 |
Christ, M; Haid, M; Hatfield, A; Johnson, CM; Khandekar, JD; Lanzotti, V; Locker, GY; Merrill, JM; Miller, SJ; Reisel, H | 1 |
Alegría, E; Antón Aparicio, LM; Calvo, FA; Dy, C; Gil, A; Harguindey, S; Martinez Lage, M; Pastor, MA; Zubieta, JL | 1 |
9 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Brain Neoplasms
Article | Year |
---|---|
Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cell Line; Cell Survival; Cyclohexenes; Eflornithine; Kinetics; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Rats | 1984 |
Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Child; Cyclohexenes; Drug Evaluation; Female; Humans; Male; Middle Aged | 1983 |
Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Cyclohexenes; Drug Therapy, Combination; Glioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Procarbazine | 1983 |
Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cyclohexenes; Glioma; Humans; Lomustine | 1990 |
Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cerebellar Neoplasms; Cyclohexenes; Drug Evaluation; Ependymoma; Female; Glioblastoma; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Staging; Oligodendroglioma; Risk | 1985 |
Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Colony-Forming Units Assay; Cyclohexenes; Glioma; Humans; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1988 |
Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Cyclohexenes; Glioma; Hot Temperature; Humans; Hydantoins; In Vitro Techniques; Nitrogen Mustard Compounds | 1987 |
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
Topics: Adolescent; Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cyclohexenes; Drug Evaluation; Glioma; Humans; Leukopenia; Middle Aged; Nausea; Radiography; Vomiting | 1985 |
Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclohexenes; Female; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Radionuclide Imaging | 1985 |